Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors

Antimicrob Agents Chemother. 1985 Nov;28(5):708-10. doi: 10.1128/AAC.28.5.708.

Abstract

Nalidixic acid-resistant mutants of Campylobacter jejuni and C. coli as well as "C. laridis" strains showed cross-resistance to another DNA gyrase subunit A inhibitor, enoxacin (MIC, 32 micrograms/ml), whereas C. fetus subsp. fetus, C. fetus subsp. venerealis, and "C. hyointestinalis" strains were all susceptible to enoxacin (MIC, less than or equal to 2 micrograms/ml). All Campylobacter species were resistant to novobiocin (MIC, 32 to 512 micrograms/ml), but most strains were susceptible to the other DNA gyrase subunit B inhibitors coumermycin A1 and clorobiocin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Campylobacter / drug effects*
  • Campylobacter / genetics
  • Drug Resistance, Microbial
  • Enoxacin
  • Microbial Sensitivity Tests
  • Mutation
  • Nalidixic Acid / pharmacology*
  • Naphthyridines / pharmacology*
  • Topoisomerase II Inhibitors*

Substances

  • Anti-Bacterial Agents
  • Naphthyridines
  • Topoisomerase II Inhibitors
  • Enoxacin
  • Nalidixic Acid